AMAG Pharma (AMAG) Tops Q3 EPS by 31c

November 3, 2016 7:06 AM EDT

Get instant alerts when news breaks on your stocks. Claim your 2-week free trial to StreetInsider Premium here.

AMAG Pharma (NASDAQ: AMAG) reported Q3 EPS of $1.81, $0.31 better than the analyst estimate of $1.50. Revenue for the quarter came in at $143.8 million versus the consensus estimate of $141.48 million.

GUIDANCE:

AMAG Pharma sees FY2016 revenue of $523-553 million, versus prior guidance of $503-553 million and the consensus of $543.0 million.

For earnings history and earnings-related data on AMAG Pharma (AMAG) click here.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In






Related Categories

Earnings, Guidance

Related Entities

Earnings

Add Your Comment